Journal of Cancer Therapy
Vol.6 No.10(2015), Paper ID 59501, 12
pages
DOI:10.4236/jct.2015.610094
A Single Institutional Phase II Randomized Trial of Whole Brain Radiation Therapy with or without Irinotecan for the Treatment of Brain Metastases from Solid Tumours
Soheir S. Ismail, Soheir H. Mahmoud, Dina A. Salem, Ahmed E. Essa, Diaa El-Din M. Sherif
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Copyright © 2015 Soheir S. Ismail, Soheir H. Mahmoud, Dina A. Salem, Ahmed E. Essa, Diaa El-Din M. Sherif et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Ismail, S. , Mahmoud, S. , Salem, D. , Essa, A. and Sherif, D. (2015) A Single Institutional Phase II Randomized Trial of Whole Brain Radiation Therapy with or without Irinotecan for the Treatment of Brain Metastases from Solid Tumours.
Journal of Cancer Therapy,
6, 859-870. doi:
10.4236/jct.2015.610094.